 BOSTON, Jan. 04, 2022 GLOBE NEWSWIRE -- Monte Rosa Therapeutics, Inc. NASDAQ: GLUE, a biotechnology company developing novel molecular glue degrader medicines, today announced that the company is scheduled to present at the virtual 40th Annual J.P. Morgan Healthcare Conference at 5:15 p.m. ET on Tuesday, January 11, 2022. 